Rationale and Methods for a Trial Assessing Placebo, Echinacea, and Doctor-Patient Interaction in the Common Cold

Explore: The Journal of Science and Healing

Volumn 3, Issue 6, 2007, Pages 561-572

  Barrett, Bruce ^a   Rakel, Dave ^a   Chewning, Betty ^b   Marchand, Lucille ^a   Rabago, David ^a   Brown, Roger ^b   Scheder, Jo ^b   Schmidt, Raandi ^b   Gern, James E ^a   Bone, Kerry ^c,d   Thomas, Gay ^a   Barlow, Shari ^a   Bobula, James ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of New England ^*  (Australia)

^d UNIVERSITY OF NEW ENGLAND   (Australia)

Author keywords

Clinical trials; common cold; communication; double blind method; physician patient relations; placebo effect; placebos; respiratory infection; therapeutics; treatment outcome

Indexed keywords

ECHINACEA EXTRACT; INTERLEUKIN 8; PLACEBO;

AFFECT; ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG EFFICACY; EMPATHY; EMPOWERMENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; OPEN STUDY; OPTIMISM; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SOCIAL SUPPORT; STRESS; TREATMENT OUTCOME;

COMMON COLD; DOUBLE-BLIND METHOD; ECHINACEA; HUMANS; PATIENT COMPLIANCE; PATIENT SELECTION; PHYSICIAN-PATIENT RELATIONS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 36148942487     PISSN: 15508307     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.explore.2007.08.001     Document Type: Article

References (189)

1. Friedman L.M., Furberg C.D., and DeMets D.L. Fundamentals of Clinical Trials (1998), Springer-Verlag, New York, NY
2. Guyatt G.H., and Rennie D. Users' Guides to the Literature: A Manual for Evidence-Based Clinical Practice (2002), AMA Press, Chicago, Ill
3. Benson K., and Hartz A.J. A comparison of observational studies and randomized, controlled trials. N Engl J Med 342 (2000) 1878-1886
4. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342 (2000) 1887-1892
5. Kunz R., and Oxman A.D. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 317 (1998) 1185-1190
6. McKee M., Britton A., Black N., McPherson K., Sanderson C., and Bain C. Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ 319 (1999) 312-315
7. Ottenbacher K. Impact of random assignment on study outcome: an empirical examination. Control Clin Trials 13 (1992) 50-61
8. Pocock S.J., and Elbourne D.R. Randomized trials or observational tribulations?. N Engl J Med 342 (2000) 1907-1909
9. Basoglu M., Marks I., Livanou M., and Swinson R. Double-blindness procedures, rater blindness, and ratings of outcome: observations from a controlled trial. Arch Gen Psychiatry 54 (1997) 744-748
10. Berlin J.A., and Rennie D. Measuring the quality of trials: the quality of quality scales. JAMA 282 (1999) 1083-1085
11. Caspi O., Millen C., and Sechrest L. Integrity and research: introducing the concept of dual blindness. How blind are double-blind clinical trials in alternative medicine?. J Altern Complement Med 6 (2000) 493-498
12. Devereaux P.J., Manns B.J., Ghali W.A., et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 285 (2001) 2000-2003
13. Jadad-Bechara A.R., Moore R.A., and Carrol D. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
14. Engel L.W., Guess H.A., Kleinman A., and Kusek J.W. The Science of the Placebo: Toward an Interdisciplinary Research Agenda (2002), BMJ Books, London, England
15. Harrington A. The Placebo Effect: An Interdisciplinary Exploration (1997), Harvard University Press, Cambridge, Mass
16. Moerman D.E. Meaning, Medicine and the 'Placebo Effect' (2002), Cambridge University Press, Cambridge, NY
17. Kirsch I. How Expectancies Shape Experience (1999), American Psychological Association, Washington, DC
18. Shapiro A.K., and Shapiro E. The Powerful Placebo: From Ancient Priest to Modern Physician (1997), Johns Hopkins University Press, Baltimore, Md
19. Barrett B., Muller D., Rakel D., Rabago D., Marchand L., and Scheder J. Placebo, meaning and health. Perspect Biol Med 49 (2006) 178-198
20. Grufferman S. Complexity and the Hawthorne effect in community trials. Epidemiology 10 (1999) 209-210
21. Hsueh Y. The Hawthorne experiments and the introduction of Jean Piaget in American industrial psychology, 1929-1932. Hist Psychol 5 (2002) 163-189
22. Wickstrom G., and Bendix T. The "Hawthorne effect"-what did the original Hawthorne studies actually show?. Scand J Work Environ Health 26 (2000) 363-367
23. Mead N., and Bower P. Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med 51 (2000) 1087-1110
24. Flocke S.A., Miller W.L., and Crabtree B.F. Relationships between physician practice style, patient satisfaction, and attributes of primary care. J Fam Pract 51 (2002) 835-840
25. Moerman D. Doctors and patients: the role of clinicians in the placebo effect. Adv Mind Body Med 19 (2003) 14-22
26. Roter D.L., and Hall J.A. Studies of doctor-patient interaction. Ann Rev Public Health 10 (1989) 163-180
27. Stewart M.A. Effective physician-patient communication and health outcomes: a review. Can Med Assoc J 152 (1995) 1423-1433
28. Barsky A.J., Saintfort R., Rogers M., and Borus J.F. Nonspecific medication side effects and the nocebo phenomenon. JAMA 287 (2002) 622-627
29. Bouchet C., Guillemin F., and Briancon S. Nonspecific effects in longitudinal studies: impact on quality of life measures. J Clin Epidemiol 49 (1996) 15-20
30. Kirsch I. Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A. (Ed). The Placebo Effect: An Interdisciplinary Exploration (1997), Harvard University Press, Cambridge Mass 166-186
31. Di Blasi Z., Harkness E., Ernst E., Georgiou A., and Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet 357 (2001) 757-762
32. Di Blasi Z., and Kleijnen J. Context effects. Powerful therapies or methodological bias?. Eval Health Prof 26 (2003) 166-179
33. Thomas K.B. General practice consultations: is there any point in being positive?. BMJ 294 (1987) 1200-1203
34. Barrett B.P., Brown R.L., Locken K., Maberry R., Bobula J.A., and D'Alessio D. Treatment of the common cold with unrefined echinacea: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 137 (2002) 939-946
35. Barrett B., Locken K., Maberry R., et al. The Wisconsin Upper Respiratory Symptom Survey: development of an instrument to measure the common cold. J Fam Pract 51 (2002) 265-273
36. Barrett B., Brown R., Mundt M., et al. The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid. J Clin Epidemiol 58 (2005) 609-617
37. Barrett B., Brown R., Voland R., Maberry R., and Turner R. Relations among questionnaire and laboratory measures of rhinovirus infection. Eur Respir J 28 (2006) 358-363
38. Barrett B, Mundt MP, Brown RE. Assessing important difference and responsiveness in common cold. Qual Life Res. In press.
39. Barrett B., Vohmann M., and Calabrese C. Echinacea for upper respiratory infection: evidence-based clinical review. J Fam Pract 48 (1999) 628-635
40. Caruso T.J., and Gwaltney Jr. J.M. Treatment of the common cold with echinacea: a structured review. Clin Infect Dis 40 (2005) 807-810
41. Giles J.T., Palat C.T., Chien S.H., Chang Z.G., and Kennedy D.T. Evaluation of Echinacea for treatment of the common cold. Pharmacotherapy 20 (2000) 690-697
42. Kligler B. Echinacea. Am Fam Physician 67 (2003) 77-80
43. Linde K., Barrett B., Wolkart K., Bauer R., and Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev (2006) (1):CD000530
44. Melchart D., Linde K., Fischer P., and Kaesmayr J. Echinacea for preventing and treating the common cold. Cochrane Library Issue 4 (2000)
45. Barrett B., Locken K., Maberry R., et al. The Wisconsin Upper Respiratory Symptom Survey: development of an instrument to measure the common cold. J Fam Pract 51 (2002) 265-273
46. Jackson G.G., Dowling H.F., Spiesman I.G., and Boand A.V. Transmission of the common cold to volunteers under controlled conditions. Arch Intern Med 101 (1958) 267-278
47. Jackson G.G., Dowling H.F., Anderson T.O., Riff L., Saporta J., and Turck M. Susceptibility and immunity to common upper respiratory viral infections-the common cold. Ann Intern Med 55 (1960) 719-738
48. Jackson G.G., Dowling H.F., and Muldoon R.L. Present concepts of the common cold. Am J Public Health 52 (1962) 940-945
49. Balint M. Is the therapeutic nature of the patient-physician relationship being undermined?. Arch Intern Med 160 (2000) 2257-2259
50. Bass M.J., Buck C., Turner L., Dickie G., Pratt G., and Robinson H.C. The physician's actions and the outcome of illness in family practice. J Fam Pract 23 (1986) 43-47
51. Brody H. Placebo response, sustained partnership, and emotional resilience in practice. J Am Board Fam Pract 10 (1997) 72-74
52. Charon R. The patient-physician relationship. Narrative medicine: a model for empathy, reflection, profession and trust. JAMA 286 (2001) 1897-1902
53. Chewning B., and Sleath B. Medication decision-making and management: a client-centered model. Soc Sci Med 42 (1996) 389-398
54. Egbert L.D., Battit G.E., Welch C.E., and Bartlett M.K. Reduction of post-operative pain by encouragement and instruction of patients. NEJM 270 (1964) 825-827
55. Kaplan S.H., Greenfield S., and Ware J.E. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 27 (1989) S110-S127
56. Krupat E., Bell R.A., Kravitz R.L., Thom D., and Azari R. When physicians and patients think alike: patient-centered beliefs and their impact on satisfaction and trust. J Fam Pract 50 (2001) 1057-1062
57. Latham C.E. Is there data to support the concept that educated, empowered patients have better outcomes?. J Am Soc Nephrol 9 suppl 4 (1998) S141-S144
58. Levenstein J.H., McCracken E.C., McWhinney I.R., Stewart M.A., and Brown J.B. The patient-centred clinical method. 1. A model for the doctor-patient interaction in family medicine. Fam Pract 3 (1986) 24-30
59. Pappas S., and Perlman A. Complementary and alternative medicine. The importance of doctor-patient communication. Med Clin North Am 86 (2002) 1-10
60. Reilly D. Enhancing human healing. BMJ 322 (2001) 120-121
61. Roter D.L., Hall J.A., Kern D.E., Barker L.R., Cole K.A., and Roca R.P. Improving physicians' interviewing skills and reducing patients' emotional distress. A randomized clinical trial. Arch Intern Med 155 (1995) 1877-1884
62. Simpson M., Buckman R., Stewart M., et al. Doctor-patient communication: the Toronto consensus statement. BMJ 303 (1991) 1385-1387
63. Starfield B., Wray C., Hess K., Gross R., Birk P.S., and D'Lugoff B.C. The influence of patient-practitioner agreement on outcome of care. Am J Public Health 71 (1981) 127-131
64. Stewart M., Brown J.B., Boon H., Galajda J., Meredith L., and Sangster M. Evidence on patient-doctor communication. Cancer Prev Control 3 (1999) 25-30
65. Suchman A.L., Markakis K., Beckman H.B., and Frankel R. A model of empathic communication in the medical interview. JAMA 277 (1997) 678-682
66. Thomas K.B. The consultation and the therapeutic illusion. BMJ 1 (1978) 1327-1328
67. Roter D.L., Hall J.A., Merisca R., Nordstrom B., Cretin D., and Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 36 (1998) 1138-1161
68. Roter D.L., and Hall J.A. Doctors Talking with Patients: Patients Talking with Doctors: Improving Communication in Medical Visits (1992), Auburn House, Westport Conn
69. Flood A.B., Lorence D.P., Ding J., McPherson K., and Black N.A. The role of expectations in patients' reports of post-operative outcomes and improvement following therapy. Med Care 31 (1993) 1043-1056
70. Little P., Everitt H., Williamson I., et al. Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ 323 (2001) 908-911
71. Mondloch M.V., Cole D.C., and Frank J.W. Does how you do depend on how you think you'll do?. A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes. Can Med Assoc J 165 (2001) 174-179
72. Petrie K.J., Weinman J., Sharpe N., and Buckley J. Role of patients' view of their illness in predicting return to work and functioning after myocardial infarcation: longitudinal study. BMJ 312 (1996) 1191-1194
73. Ryff C.D. Positive mental health. In: Blechman E.A., and Brownell K.D. (Eds). Behavioral Medicine and Women: A Comprehensive Handbook (1998), Guilford Publications, Inc, New York, NY 183-188
74. Savage R., and Armstrong D. Effect of a general practitioner's consulting style on patients' satisfaction: a controlled study. BMJ 301 (1990) 968-970
75. Roter D.L., and Hall J.A. Patient-provider communication. In: Glanz K., Lewis F.M., and Rimer B.K. (Eds). Health Behavior and Health Education: Theory, Research and Practice (1997), Jossey-Bass, A Wiley Company, San Francisco, Calif 206-226
76. Evans R.G., Barer M.L., and Marmot T.R. Why are Some People Healthy and Others Not?. The Determinants of Health in Populations (1994), Aldine de Gruyter, New York, NY
77. Marmot M.G. Social differentials in health within and between populations. Daedalus: J Am Acad Arts Sci 123 (1994) 197-216
78. McKnight J.L. Health and empowerment. Can J Public Health suppl 1 (1985) 37-38
79. Singer B., and Ryff C.D. Hierarchies of life histories and associated health risk. Ann N Y Acad Sci 896 (1999) 95-115
80. Guadagnoli E., and Ward P. Patient participation in decision-making. Soc Sci Med 47 (1998) 329-339
81. Suchman A.L., and Matthews D.A. What makes the patient-doctor relationship therapeutic?. Exploring the connexional dimension of medical care. Ann Intern Med 108 (1988) 125-130
82. Matthews D.A., Suchman A.L., and Branch Jr. W.T. Making "connexions": enhancing the therapeutic potential of patient-clinician relationships. Ann Intern Med 118 (1993) 973-977
83. Goldberg P.E. The physician-patient relationship: three psychodynamic concepts that can be applied to primary care. Arch Fam Med 9 (2000) 1164-1168
84. Mercer S.W., and Reynolds W.J. Empathy and quality of care. Br J Gen Pract 52 suppl (2002) S9-S12
85. Mercer S.W., McConnachie A., Maxwell M., Heaney D., and Watt G.C.M. Relevance and practical use of the Consultation and Relational Empathy (CARE) Measure in general practice. Fam Pract 22 (2005) 328-334
86. Mercer S.W., Maxwell M., Heaney D., and Watt G.C.M. The consultation and relational empathy (CARE) measure: development and preliminary validation and reliability of an empathy-based consultation process measure. Fam Pract 21 (2004) 699-705
87. Hall J.A., Horgan T.G., Stein T.S., and Roter D.L. Liking in the physician-patient relationship. Patient Educ Couns 48 (2002) 69-77
88. Badia L.X., Herdman M., and Schiaffino A. Determining correspondence between scores on the EQ-5D "thermometer" and a 5-point categorical rating scale. Med Care 37 (1999) 671-677
89. Coyle D., Wells G., Graham I., Lee K.M., Peterson J.E., and Papadimitropoulos E. The impact of risk on preference values: implications for evaluations of postmenopausal osteoporosis therapy. Value Health 4 (2001) 385-391
90. Feeny D., Furlong W., Torrance G.W., et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 40 (2002) 113-128
91. Brazier J.E., Harper R., Jones N.M.B., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305 (1992) 160-164
92. Jenkinson C., Wright L., and Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res 3 (1994) 7-12
93. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
94. McHorney C.A., Ware J.E., and Raczek A.E. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31 (1998) 247-263
95. McHorney C.A., Ware J.E., Lu J.F.R., and Sherbourne C.D. The MOS 36-Item short-form health survery (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32 (1994) 40-66
96. Ware J.E., Kosinski M., Dewey J.E., and Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey (2001), QualityMetric, Lincoln, RI
97. Cobb J.M., and Steptoe A. Psychosocial stress and susceptibility to upper respiratory tract illness in an adult population sample. Psychosom Med 58 (1996) 404-412
98. Cohen S., Tyrell D.A.J., and Smith A.P. Psychological stress and susceptibility to the common cold. NEJM 325 (1991) 606-612
99. Stone A.A., Bovbjerg D.H., Neale J.M., et al. Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life events. Behav Med 18 (1992) 115-120
100. Takkouche B., Regueira C., and Gestal-Otero J.J. A cohort study of stress and the common cold. Epidemiology 12 (2001) 345-349
101. Labbate L.A., Fava M., Oleshansky M., Zoltec J., Littman A., and Harig P. Physical fitness and perceived stress. Relationships with coronary artery disease risk factors. Psychosomatics 36 (1995) 555-560
102. Malarkey W.B., Pearl D.K., Demers L.M., Kiecolt-Glaser J.K., and Glaser R. Influence of academic stress and season on 24-hour mean concentrations of ACTH, cortisol, and beta-endorphin. Psychoneuroendocrinology 20 (1995) 499-508
103. van Eck M., and Nicolson N.A. Perceived stress and salivary cortisol in daily life. Ann Behav Med 16 (1994) 221-227
104. van Eck M., Berkhof H., Nicolson N., and Sulon J. The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosom Med 58 (1996) 447-458
105. Cohen S., Underwood L.G., and Gottlieb B.H. Social Support Measurement and Intervention (2000), Oxford University Press, Oxford, UK
106. Goodwin P., Leszcz M., Ennis M., et al. The effect of group psychosocial support on survival in metastatic breast cancer. NEJM 345 (2001) 1719-1726
107. Ryff C.D., and Singer B. Interpersonal flourishing: a positive health agenda for the new millenium. Pers Soc Psychol Rev 4 (2000) 30-44
108. Cohen S., Doyle W.J., Skoner D.P., Rabin B.S., and Gwaltney J.M. Social ties and susceptibility to the common cold. JAMA 277 (1997) 1940-1944
109. Ryff C.D., and Singer B. Psychological well-being: meaning, measurement, and implications for psychotherapy research. Psychother Psychosom 65 (1996) 14-23
110. Desharnais R., Godin G., Jobin J., Valois P., and Ross A. Optimism and health-relevant cognitions after a myocardial infarction. Psychol Rep 67 (1990) t-5
111. Ryff C.D. Psychological well-being in adult life. Curr Dir Psychol Sci 4 (1995) 99-104
112. Schmutte P.S., and Ryff C.D. Personality and well-being: reexamining methods and meanings. J Pers Soc Psychol 73 (1997) 549-559
113. Scheier M.F., and Carver C.S. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 4 (1985) 219-247
114. Scheier M.F., and Carver C.S. Effects of optimism on psychological and physical well-being: theoretical overview and empirical update. Cognit Ther Res 16 (1992) 201-228
115. Cohen S., Tyrrell D.A.J., and Smith A.P. Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol 64 (1993) 131-140
116. Cohen S., Doyle W.J., Skoner D.P., Fireman P., Gwaltney J.M., and Newsom J.T. State and trait negative affect as predictors of objective and subjective symptoms of respiratory viral infections. J Pers Soc Psychol 68 (1995) 159-169
117. Cohen S., Alper C.M., Doyle W.J., Treanor J.J., and Turner R.B. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza a virus. Psychosom Med 68 (2006) 809-815
118. Albrecht R.R., and Ewing S.J. Standardizing the administration of the Profile of Mood States (POMS): development of alternative word lists. J Pers Assess 53 (1989) 31-39
119. Jacobs K.W., and Boze M.M. Correlations among scales of the Beck Depression Inventory and the profile of mood states. Psychol Rep 73 (1993) 431-434
120. Little K., and Penman E. Measuring subacute mood changes using the profile of mood states and visual analogue scales. Psychopathology 22 (1989) 42-49
121. Nyenhuis D.L., Yamamoto C., Luchetta T., Terrien A., and Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55 (1999) 79-86
122. Pollock V., Cho D.W., Reker D., and Volavka J. Profile of Mood States: the factors and their physiological correlates. J Nerv Ment Dis 167 (1979) 612-614
123. Shacham S. A shortened version of the Profile of Mood States. J Pers Assess 47 (1983) 305-306
124. Abbas A.K., Lichtman A.H., and Pober J.S. Cellular and Molecular Immunology (2000), W.B. Saunders, Philadelphia, Pa
125. Janeway C.A., Travers P., Walport M., and Capra J.D. Immunobiology: the Immune System in Health and Disease (1999), Current Biology Publications, New York, NY
126. Naclerio R.M., Proud D., Lichtenstein L.M., et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 157 (1988) 133-142
127. Teran L.M., Johnston S.L., Schroder J.M., Church M.K., and Holgate S.T. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus induced asthma. Am J Respir Crit Care Med 155 (1997) 1362-1366
128. Turner R.B. The treatment of rhinovirus infections: progress and potential. Antiviral Res 49 (2001) 1-14
129. Becker S., Koren H.S., and Henke D.C. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 8 (1993) 20-27
130. Kaul P., Biagioli M.C., Singh I., and Turner R.B. Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J Infect Dis 181 (2000) 1885-1890
131. Choi A.M.K., and Jacoby D.B. Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS 309 (1992) 327-329
132. Garofalo R., Patel J.A., Sim C., Schmalstieg F.C., and Goldman A.S. Production of cytokines by virus-infected human respiratory epithelial cells. J Allergy Clin Immunol 91 (1993) 177
133. Gern J.E., Vrtis R., Kelly E.A.B., Dick E.C., and Busse W.W. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol 157 (1996) 1605-1612
134. Johnston S.L., Papi A., Monick M.M., and Hunninghake G.W. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 175 (1997) 323
135. Noah T.L., Henderson F.W., Wortman I.A., et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171 (1995) 584-592
136. Parry D.E., Busse W.W., Sukow K.A., Dick C.R., Swenson C., and Gern J.E. Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 105 (2000) 692-698
137. Roseler S., Holtappels G., Wagenmann M., and Bachert C. Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 1 (1995) S61-S63
138. Zhu Z., Tang W., Gwaltney J.M., Wu Y., and Elias J.A. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kB. Am J Physiol 273 (1997) 814-824
139. Schroth M.K., Grimm E., Frindt P., et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 20 (1999) 1220-1228
140. Mullins R.J., and Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 88 (2002) 42-51
141. Soon S.L., and Crawford R.I. Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol 44 (2001) 298-299
142. Taylor J.A., Weber W., Standish L., et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 290 (2003) 2824-2830
143. Barrett B. Echinacea: a safety review. HerbalGram: J Am Botan 57 (2003) 36-39
144. Huntley A.L., Thompson C.J., and Ernst E. The safety of herbal medicinal products derived from echinacea species: a systematic review. Drug Safe 28 (2005) 387-400
145. Perri D., Dugoua J.J., Mills E., and Koren G. Safety and efficacy of echinacea (E. angustafolia, e. purpurea and e. pallida) during pregnancy and lactation. Can J Clin Pharmacol 13 (2006) e262-e267
146. Bentler P.M. Multivariate analysis with latent variables: causual modeling. In: Rosenzweig M.R., and Porter L.W. (Eds). Annual Review of Psychology (1980), Annual Reviews, Inc, Stanford, Conn 419-456
147. Browne M.W. Covariance structures. In: Hawkins D.M. (Ed). Topics in Applied Multivariate Analysis (1982), Cambridge University Press, Cambridge, Mass 72-141
148. Dillon W.R., and Goldstein M. Multivariate Analysis: Methods and Applications (1984), John Wiley & Sons, New York, NY
149. Huitema B.E. The Analysis of Covariance and Alternatives (1980), John Wiley & Sons, New York, NY
150. Joreskog K.A. Analysis of covariance structures. Scand J Stat 8 (1981) 65-92
151. Lewontin R. Annotation: the analysis of variance and the analysis of causes. Am J Hum Genetics 26 (1974) 400-411
152. Snedecor G.W., and Cochran W.G. Statistical Methods (1980), Iowa State University Press, Ames, IA
153. Albert J.M., and DeMets D.L. On a model-based approach to estimating efficacy in clinical trials. Stat Med 13 (1994) 2323-2335
154. Brown R.L. Assessing specific mediational effects in complex theoretical models. Struct Eq Model 4 (1997) 142-156
155. Bryk A.S., and Raudenbush S.W. Hierarchical Linear Models: Applications and Data Analysis Methods (1992), Sage, Newbury Park, Calif
156. Davis C.S. Semi-parametric and non-parametric methods for the analysis of repeated measurements with applications to clinical trials. Stat Med 1 (1991) 1959-1980
157. Goldstein H. Multilevel Statistical Models (1995), Halsted, New York, NY
158. Hedeker D., and Gibbons R.D. A random-effects ordinal regression model for multilevel analysis. Biometrics 50 (1994) 933-944
159. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
160. Littell R.C., Milliken G.A., and Wolfinger R.D. SAS System for Mixed Models (1996), SAS Institute, Inc, Cary, NC
161. Stucki G., Daltroy L., Katz J.N., Johannesson M., and Liang M.H. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 49 (1995) 711-717
162. Friedman L.M., Furberg C.D., and DeMets D.L. Sample size. Fundamentals of Clinical Trials (1998), Springer-Verlag, New York, NY 94-129
163. Gong J., Pinheiro J.C., and DeMets D.L. Estimating significance level and power comparisons for testing multiple endpoints in clinical trials. Control Clin Trials 21 (2000) 313-329
164. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 10 (1989) 407-415
165. Guyatt G.H., Bombardier C., and Tugwell P. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J 134 (1986) 889-894
166. Barrett B., Brown R., Mundt M., et al. Using benefit harm tradeoffs to estimate sufficiently important difference: the case of the common cold. Med Decis Making 25 (2005) 47-55
167. Barrett B., Brown D., Mundt M., and Brown R. Sufficiently important difference: expanding the framework of clinical significance. Med Decis Making 25 (2005) 250-261
168. Barrett B., Harahan B., Brown D., Zhang Z., and Brown R. Sufficiently important difference for common cold: severity reduction. Ann Fam Med 5 (2007) 216-223
169. Benjamini Y., and Hochberg Y. On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat 25 (2000) 60-83
170. Benjamini Y., and Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics 171 (2005) 783-790
171. Benjamini Y., and Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Roy Stat Soc B57 (1995) 289-300
172. Hochberg Y., and Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 9 (1990) 811-818
173. Hedeker D., and Gibbons R.D. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods 2 (1997) 64-78
174. Schafer J.L. Analysis of Incomplete Multivariate Data (1997), Chapman & Hall, London, England
175. Unnebrink K., and Windeler J. Intention-to-treat methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat Med 20 (2001) 3931-3946
176. Touloumi G., Babiker A.G., Pocok S.J., and Darbyshire J.H. Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies A simulation study. Stat Med 20 (2001) 3715-3728
177. Little R.J.A. Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc 90 (1995) 1112-1121
178. Altman D.G. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 313 (1996) 570-571
179. Moher D., Schulz K.F., and Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
180. Ioannidis J.P., Evans S.J., Gotzsche P.C., et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141 (2004) 781-788
181. De Angelis C.D., Drazen J.M., Frizelle F.A., et al. Is this clinical trial fully registered?-a statement from the International Committee of Medical Journal Editors. N Engl J Med 352 (2005) 2436-2438
182. Dickersin K., and Rennie D. Registering clinical trials. JAMA 290 (2003) 516-523
183. Kaptchuk T.J. Powerful placebo: the dark side of the randomised controlled trial. Lancet 351 (1998) 1722-1725
184. Kaptchuk T.J. Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bull Hist Med 72 (1998) 389-433
185. Kaptchuk T.J. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf?. J Clin Epidemiol 54 (2001) 541-549
186. Kienle G.S., and Kiene H. The powerful placebo effect: fact or fiction?. J Clin Epidemiol 50 (1997) 1311-1318
187. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless?. An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344 (2001) 1594-1602
188. Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J Altern Complement Med 7 (2001) 213-218
189. Di Blasi Z., and Reilly D. Placebos in medicine: medical paradoxes need disentangling. BMJ 330 (2005) 45